FAZIO, VITO MICHELE
 Distribuzione geografica
Continente #
AS - Asia 8.019
NA - Nord America 1.586
EU - Europa 763
SA - Sud America 450
AF - Africa 41
OC - Oceania 27
Totale 10.886
Nazione #
SG - Singapore 6.210
US - Stati Uniti d'America 1.510
CN - Cina 775
HK - Hong Kong 668
BR - Brasile 355
GB - Regno Unito 238
DE - Germania 188
VN - Vietnam 186
IT - Italia 116
IN - India 61
CA - Canada 53
AR - Argentina 39
NL - Olanda 32
UA - Ucraina 28
AU - Australia 26
FI - Finlandia 26
ID - Indonesia 24
ES - Italia 21
PL - Polonia 19
JP - Giappone 18
ZA - Sudafrica 18
CZ - Repubblica Ceca 16
MX - Messico 15
CO - Colombia 14
TR - Turchia 13
CL - Cile 12
FR - Francia 12
EC - Ecuador 10
RU - Federazione Russa 9
EG - Egitto 8
IQ - Iraq 8
AT - Austria 7
BD - Bangladesh 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
RO - Romania 6
EE - Estonia 5
CH - Svizzera 4
IR - Iran 4
PK - Pakistan 4
SA - Arabia Saudita 4
SE - Svezia 4
UY - Uruguay 4
VE - Venezuela 4
BG - Bulgaria 3
CM - Camerun 3
HU - Ungheria 3
KR - Corea 3
MA - Marocco 3
PE - Perù 3
SI - Slovenia 3
UZ - Uzbekistan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
MK - Macedonia 2
MS - Montserrat 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GD - Grenada 1
GE - Georgia 1
IE - Irlanda 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
MN - Mongolia 1
MW - Malawi 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
SN - Senegal 1
Totale 10.882
Città #
Hong Kong 666
Singapore 653
Hefei 411
Ashburn 338
Dallas 244
Boardman 228
London 200
Shanghai 127
Beijing 109
Ho Chi Minh City 78
Council Bluffs 61
Los Angeles 53
San Francisco 53
Munich 48
Santa Clara 41
Pune 38
São Paulo 33
Rome 30
Hanoi 29
Toronto 28
Washington 26
Amsterdam 22
Turku 22
Warsaw 19
New York 18
Seattle 18
Tokyo 16
Montreal 15
Brno 12
Brooklyn 12
Milan 12
West Jordan 12
Rio de Janeiro 11
Boston 10
Canberra 10
Da Nang 10
Charlotte 8
Chennai 8
Chicago 8
Haiphong 8
Manchester 8
Melbourne 8
Thái Bình 7
Brasília 6
Guangzhou 6
Jakarta 6
Johannesburg 6
Quito 6
Redwood City 6
Sydney 6
Biên Hòa 5
Buffalo 5
Fortaleza 5
Guarulhos 5
Hanover 5
Macaé 5
Mexico City 5
Oklahoma City 5
Porto Alegre 5
Queens 5
Sona 5
Asunción 4
Atlanta 4
Denver 4
Hải Dương 4
Laives 4
Maceió 4
Magé 4
Montevideo 4
Phoenix 4
Phủ Lý 4
Poplar 4
Ribeirão Preto 4
Santo André 4
Secaucus 4
Sumaré 4
Vienna 4
Ankara 3
Baghdad 3
Bagé 3
Bandung 3
Baqubah 3
Belo Horizonte 3
Bogotá 3
Bologna 3
Budapest 3
Bắc Giang 3
Cachoeiro de Itapemirim 3
Caracas 3
Caxias do Sul 3
Florence 3
Helsinki 3
Hortolândia 3
Lincoln 3
Ljubljana 3
Lomas de Zamora 3
Madison 3
Maringá 3
Morciano di Romagna 3
Mumbai 3
Totale 3.998
Nome #
DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor 298
Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors 227
Bilateral consecutive rupture of the quadriceps tendon in a man with BstUI polymorphism of the COL5A1 gene Reply 207
A miRNA signature for defining aggressive phenotype and prognosis in gliomas. 196
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 195
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 193
Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens 190
ANTI-IDIOTYPIC CDR3 VACCINATION AGAINST CHRONIC B-CELL LYMPHOMA: DNA VACCINE STRATEGY 188
ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice 186
EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents? 182
Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6 179
The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies 179
A plasmid family containing two different expression cassettes suitable for immuno-modulation and genetic immunization 179
Aberrant Keap1 methylation in breast cancer and association with clinicopathological features. 179
Erratum:The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation [EMBO Mol Med, 5, (2013) 1523-1536, DOI: 10.1002/emmm.201302847] 179
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches 175
Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma 163
Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids 151
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 110
Impact of Histology and Tumor Grade on Clinical Outcomes Beyond 5 Years of Follow-Up in a Large Cohort of Renal Cell Carcinomas 106
Mapping Non-Coding RNAs in Space and Time: Another Weapon to Dissect Intra-Tumor Heterogeneity in Cancer Progression 106
Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models? 106
Enhanced portal flow velocity and volume following Iloprost treatment 104
Up-regulation of Ku heterodimer expression and DNA-End binding activity in human colorectal carcinogenesis 103
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 102
Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies 101
Characterizing the tumor microenvironment in rare renal cancer histological types 99
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy 98
Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer 97
Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression 97
Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma. 95
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 95
A genomics-based classification of human lung tumors. 94
Butein-instigated miR-186-5p-dependent modulation of TWIST1 affects resistance to cisplatin and bioenergetics of Malignant Pleural Mesothelioma cells 93
[Identification of candidate genes and expression profiles, as doping biomarkers] 93
Strategies to elicit anti-idiotypic immune response in B-lymphoma patients: peptide and genetic immunization 92
EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers. 91
A Combined Analytical Approach Reveals Novel EXT1/2 Gene Mutations In A Large Cohort Of Italian Multiple Osteochondromas Patients 91
A malignant inflammatory myofibroblastic tumor of the hypopharynx harboring the 3a/b variants of the EML4-ALK fusion gene. 90
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 89
317 POSTER APC, CDH1 and CTNN1B promoter CpG islands methylation patterns during ductal breast carcinoma progression 89
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 89
4-hudroxynonenal: an andogenous signal for cell proliferation and differentiation 88
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 88
Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer. 86
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 86
Bilateral consecutive rupture of the quadriceps tendon in a man with BstUI polymorphism of the COL5A1 gene 86
4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells 85
"Naked" DNA transfer technology for genetic vaccination against infectious disease 84
Tumor cells in light-chain amyloidosis and myeloma show different transcriptional rewiring of normal plasma cell development 84
4- hydrozunonenal action on cell cycle and differentiation of HL-60 cells 82
A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions 81
4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells 80
4-Hydroxynonenal-induced MEL cell differentiation involves PKC activity translocation 80
4-hydroxynonenal action on cell cycle and differentiation of HL-60 cells 78
Insights into intra-tumoral heterogeneity: Transcriptional profiling of chemoresistant mpm cell subpopulations reveals involvement of nfkb and dna repair pathways and contributes a prognostic signature 78
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation 68
Una nuova frontiera per la dermatologia: la cute come bersaglio per il trasferimento genico e la terapia genica somatica 53
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity 52
The post-surgical long-term behaviour of lung carcinoid tumours 49
Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients. 47
Frequency of Hsa-miR9 aberrant methylation in metastatic breast cancers. 47
Effect of 4-hydroxynonenal, a product of lipid peroxidation, on natural cell mediated cytotoxicity 44
Efficient transfection of adherent cells using cell suspensions 44
Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: Transgene expression, immunity and safety 43
Effect of 4-Hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells 41
Strategies to elicit anti-idiotypic immune response in B-lynphoma patients: peptide and genetic immunization 41
Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel. 41
High frequency of mitochondria DNA mutations in breast cancer: potential application for cancer detection 40
Principi di terapia genica somatica 39
Antitumoral antigenic peptides and vaccines thereof 39
Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2 38
Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage 38
Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients 37
Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia 37
Identification of a mononucleotide repeat as a major target for mitochondrial DNA mutations in human tumors. Detailed screening and pattern of alterations in lung and head and neck tumors 37
nrf2-keap1 axis molecular profile in small cell lung cancer cell lines 36
High frequency of mitochondrial DNA mutations in breast cancer: potential application for cancer detection 36
Development of a multigenic plasmid vector for HCV DNA immunization 36
Study on the feasibility of phosphorothioate modification for the construction and expression of nuclease-resistant genes 35
Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients 34
Mouse monoclonal antibodies in biological research: strategies for high-throughput production 34
Sensitive detection of transitional-cell carcinoma of the bladder by microsatellites analysis of exfoliated cells in urine 33
Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors. 33
Effect of bioactive aldehydes on cell proliferation and c-myc expression in HL-60 human leukemic cells 33
Phase specific microRNA deregulation of oncogenesis and stemness in a mouse model of sporadic CRC 33
Comparison and critical analysis of robotized technology for monoclonal antibody high-throughput production 33
Multi-cistronic vectors for gene transfer protocols 32
Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome 32
Molecular dissection of the VHL gene in solitary capillary hemangioblastoma of the central nervous system. 32
Strategies for effective naked-DNA vaccination against infectious diseases 31
Antigenic features of protein carriers commonly used in immunisation trials 31
Vaccini a DNA: l’immunizzazione genetica 31
Combined analysis of miR-200 family and its significance for breast cancer 31
USE OF PROSTACYCLIN AND ANALOGS THEREOF FOR IMPROVING VENOUS FLOW 31
The Missing ApoE Allele 31
DNA vaccines ezpressing hypervariable VH-CDR3 idiotipic determinants 31
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation. 31
Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma. 30
VHL gene alterations in Italian patients with isolated renal cell carcinomas 30
Totale 8.597
Categoria #
all - tutte 85.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022335 0 13 15 19 4 8 4 8 7 10 2 245
2022/202379 7 1 4 5 4 4 8 4 0 0 39 3
2023/2024677 28 69 29 43 68 311 6 42 3 29 21 28
2024/20257.693 87 70 396 116 34 161 102 45 506 582 2.443 3.151
2025/20262.128 563 300 422 842 1 0 0 0 0 0 0 0
Totale 10.912